Cytosorbents EBITDA 2010-2025 | CTSO
Cytosorbents ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cytosorbents Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-15 |
| 2023 | $-30 |
| 2022 | $-30 |
| 2021 | $-22 |
| 2020 | $-9 |
| 2019 | $-18 |
| 2018 | $-15 |
| 2017 | $-10 |
| 2016 | $-11 |
| 2015 | $-9 |
| 2014 | $-7 |
| 2013 | $-4 |
| 2012 | $-3 |
| 2011 | $-3 |
| 2010 | $-3 |
| 2009 | $-3 |
| Cytosorbents Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-3 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-4 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-6 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-6 |
| 2022-09-30 | $-9 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-8 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-5 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-2 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-5 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-2 |
| 2015-03-31 | $-2 |
| 2014-12-31 | $-3 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-1 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-1 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $0 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-1 |
| 2009-12-31 | $-1 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.056B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.878B | 26.72 |
| Boston Scientific (BSX) | United States | $152.546B | 36.38 |
| Stryker (SYK) | United States | $143.342B | 29.18 |
| EssilorLuxottica (ESLOY) | France | $134.414B | 0.00 |
| Medtronic (MDT) | Ireland | $114.542B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.355B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.554B | 23.72 |
| ResMed (RMD) | United States | $41.123B | 29.37 |
| Agilent Technologies (A) | United States | $32.165B | 20.97 |
| GE HealthCare Technologies (GEHC) | United States | $31.941B | 15.01 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Insulet (PODD) | United States | $19.515B | 76.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.034B | 11.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.548B | 0.00 |
| Baxter (BAX) | United States | $11.546B | 8.93 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.193B | 26.27 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.640B | 16.58 |
| Lantheus Holdings (LNTH) | United States | $3.589B | 9.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.275B | 22.92 |
| Perrigo (PRGO) | Ireland | $3.246B | 8.11 |
| ICU Medical (ICUI) | United States | $3.123B | 23.03 |
| LeMaitre Vascular (LMAT) | United States | $2.106B | 45.26 |
| AtriCure (ATRC) | United States | $1.815B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.585B | 10.02 |
| Green Thumb Industries (GTBIF) | United States | $1.454B | 62.46 |
| AdaptHealth (AHCO) | United States | $1.329B | 18.94 |
| Acuren (TIC) | United States | $1.217B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.126B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| Neogen (NEOG) | United States | $1.036B | 16.45 |
| BioLife Solutions (BLFS) | United States | $1.009B | 0.00 |
| InMode (INMD) | Israel | $0.884B | 8.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.743B | 0.00 |
| Valneva SE (VALN) | France | $0.697B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.621B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.46 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.497B | 4.12 |
| CeriBell (CBLL) | United States | $0.462B | 0.00 |
| SNDL (SNDL) | Canada | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.412B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.354B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.290B | 10.67 |
| Quanterix (QTRX) | United States | $0.280B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.255B | 18.97 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Sanara MedTech (SMTI) | United States | $0.218B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.211B | 6.33 |
| Exagen (XGN) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.194B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.150B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.27 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.75 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Veru (VERU) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 42.86 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |